Black Rock Inc. Adma Biologics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,644,711 shares of ADMA stock, worth $324 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,644,711
Previous 18,199,277
2.45%
Holding current value
$324 Million
Previous $120 Million
73.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Vanguard Group Inc Valley Forge, PA18.1MShares$315 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$226 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$220 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$150 Million0.01% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL6.58MShares$114 Million0.04% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.42B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...